Research
Adenovirus-based vaccines have shown great promise in clinical trials for a number of diseases, such as Ebola, and form an important component of modern disease fighting strategies including COVID-19 vaccine research.
The findings of this feasibility study will be disseminated to low and middle-income countries through the EPSRC Vax-Hub, ensuring the NHC’s research has a global impact.
